Order Article Reprints

Huang Y, Hejazi NS, Blette B, Carpp LN, Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, et al. Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial. Viruses. 2023; 15(10):2029. https://doi.org/10.3390/v15102029

Huang, Ying, Nima S. Hejazi, Bryan Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly E. Janes, Weiping Deng, and et al. 2023. "Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial" Viruses 15, no. 10: 2029. https://doi.org/10.3390/v15102029

Huang, Y., Hejazi, N. S., Blette, B., Carpp, L. N., Benkeser, D., Montefiori, D. C., McDermott, A. B., Fong, Y., Janes, H. E., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., Flach, B., Lin, B. C., O’Connell, S., McDanal, C., Eaton, A., ... United States Government (USG)/CoVPN Biostatistics Teams. (2023). Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial. Viruses, 15(10), 2029. https://doi.org/10.3390/v15102029